Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking

American Journal of Epidemiology

Volumn 174, Issue 5, 2011, Pages 574-581

  Lachance, Daniel H ^a   Yang, Ping ^a   Johnson, Derek R ^a   Decker, Paul A ^a   Kollmeyer, Thomas M ^a   McCoy, Lucie S ^b   Rice, Terri ^b   Xiao, Yuanyuan ^b   Ali Osman, Francis ^d   Wang, Frances ^d   Stoddard, Shawn M ^a   Sprau, Debra J ^a   Kosel, Matthew L ^a   Wiencke, John K ^b,c   Wiemels, Joseph L ^b,c   Patoka, Joseph S ^b   Davis, Faith ^e   McCarthy, Bridget ^e   Rynearson, Amanda L ^a   Worra, Joel B ^a   Fridley, Brooke L ^a   O'Neill, Brian Patrick ^a   Buckner, Jan C ^a   Il'Yasova, Dora ^d   Jenkins, Robert B ^a   Wrensch, Margaret R ^b,c   more..

^a Mayo Clinic   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE CANCER INSTITUTE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

allergy and immunology; glioma; hypersensitivity; polymorphism, single nucleotide

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ALLELE; ALLERGY; DATA SET; GEOGRAPHICAL REGION; OBSERVATIONAL METHOD; POLYMORPHISM; RISK FACTOR; SMOKING; TUMOR;

ADULT; ALLELE; ALLERGY; ARTICLE; CANCER GRADING; CANCER RISK; CHROMOSOME 20Q; CHROMOSOME 9P; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GLIOMA; HETEROZYGOTE; HIGH GRADE GLIOMA; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; UNITED STATES;

ALLELES; ASTROCYTOMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

UNITED STATES;

EID: 80052200954     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr124     Document Type: Article

References (43)

1. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98(21):1528-1537. (Pubitemid 44680904)
2. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet. 1999;354(9172):34-39. (Pubitemid 29304300)
3. Linos E, Raine T, Alonso A, et al. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20): 1544-1550. (Pubitemid 351767237)
4. Efird JT, Friedman GD, Sidney S, et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managedcare cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004;68(1):57-69. (Pubitemid 39139557)
5. Holick CN, Giovannucci EL, Rosner B, et al. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol. 2007;9(3):326-334. (Pubitemid 47179573)
6. Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer. 2006; 118(7):1848-1851. (Pubitemid 43376453)
7. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278-299.
8. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with highgrade glioma susceptibility [letter]. Nat Genet. 2009;41(8): 905-908.
9. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
10. Schoemaker MJ, Robertson L, Wigertz A, et al. Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol. 2010;171(11):1165-1173.
11. Il'yasova D, McCarthy B, Marcello J, et al. Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1232-1238.
12. Rankin KM, Rauscher GH, McCarthy B, et al. Comparing the reliability of responses to telephone-administered versus selfadministered Web-based surveys in a case-control study of adult malignant brain cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2639-2646.
13. Vena JE, Bona JR, Byers TE, et al. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol. 1985; 122(1):66-74. (Pubitemid 15010436)
14. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005; 60(9):1098-1111. (Pubitemid 41153134)
15. Linabery AM, Jurek AM, Duval S, et al. The association between atopy and childhood/adolescent leukemia: a metaanalysis. Am J Epidemiol. 2010;171(7):749-764.
16. Ellison-Loschmann L, Benavente Y, Douwes J, et al. Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol Biomarkers Prev. 2007; 16(7):1492-1498. (Pubitemid 47076884)
17. Grulich AE, Vajdic CM, Riminton S, et al. Re: Atopy and risk of non-Hodgkin lymphoma [letter]. J Natl Cancer Inst. 2007; 99(18):1417. (Pubitemid 351767183)
18. Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-6489.
19. Gandini S, Lowenfels AB, Jaffee EM, et al. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1908-1916. (Pubitemid 41161199)
20. Synnerstad I, Fredrikson M, Ternesten-Bratel A, et al. Low risk of melanoma in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22(12):1423-1428.
21. Vojtechova P, Martin RM. The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer Causes Control. 2009;20(7):1091-1105.
22. Wang H, Rothenbacher D, Löw M, et al. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119(3):695-701. (Pubitemid 43959275)
23. Wiemels JL, Wilson D, Patil C, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009; 125(3):680-687.
24. Wrensch M, Wiencke JK, Wiemels J, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006;66(8):4531-4541.
25. Koebel CM, Vermi W, Swann JB, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 2007; 450(7171):903-907. (Pubitemid 350231320)
26. Teng MW, Swann JB, Koebel CM, et al. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol. 2008; 84(4):988-993.
27. Hancock DB, Romieu I, Shi M, et al. Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children [electronic article]. PLoS Genet. 2009;5(8):e1000623.
28. Weiss ST, Raby BA, Rogers A. Asthma genetics and genomics 2009. Curr Opin Genet Dev. 2009;19(3):279-282.
29. Weidinger S, Gieger C, Rodriguez E, et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus [electronic article]. PLoS Genet. 2008;4(8): e1000166.
30. Amirian E, Liu Y, Scheurer ME, et al. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol. 2010;12(5):444-452.
31. Scheurer ME, Amirian E, Cao Y, et al. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res. 2008;14(20): 6640-6646.
32. Schwartzbaum JA, Huang K, Lawler S, et al. Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. Neuro Oncol. 2010;12(4):320-327.
33. Wiemels JL, Wiencke JK, Kelsey KT, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16(6): 1229-1235. (Pubitemid 46984964)
34. Bahuau M, Vidaud D, Jenkins RB, et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 1998;58(11):2298-2303. (Pubitemid 28252682)
35. Koduru PR, Zariwala M, Soni M, et al. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Blood. 1995;86(8): 2900-2905.
36. Sharpless NE, Bardeesy N, Lee KH, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 2001;413(6851):86-91. (Pubitemid 32843493)
37. Sandhu C, Garbe J, Bhattacharya N, et al. Transforming growth factor b stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol. 1997;17(5):2458-2467. (Pubitemid 27175126)
38. Mattei F, Schiavoni G, Tough DF. Regulation of immune cell homeostasis by type I interferons. Cytokine Growth Factor Rev. 2010;21(4):227-236.
39. Barber LJ, Youds JL, Ward JD, et al. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell. 2008;135(2):261-271.
40. Hur EM, Son M, Lee OH, et al. LIME, a novel transmembrane adaptor protein, associates with p56lck and mediates T cell activation. J Exp Med. 2003;198(10):1463-1473. (Pubitemid 37467161)
41. Tedoldi S, Paterson JC, Hansmann M, et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood. 2006;107(1):213-221. (Pubitemid 43053546)
42. Jenkins RB, Wrensch MR, Johnson D, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 2011;204(1):13-18.
43. Cui R, Kamatani Y, Takahashi A, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 2009;137(5):1768-1775.